首页 > 市场调查报告书 > 製药

医药分析测试外包市场规模、份额及成长分析（按类型、应用、最终用户和地区划分）－产业预测，2026-2033年

市场调查报告书

商品编码

1896770

医药分析测试外包市场规模、份额及成长分析（按类型、应用、最终用户和地区划分）－产业预测，2026-2033年

Pharmaceutical Analytical Testing Outsourcing Market Size, Share, and Growth Analysis, By Type (Active Pharmaceutical Ingredient, Finished Products), By Application, By End User, By Region -Industry Forecast 2026-2033

出版日期: 2025年12月24日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，医药分析测试外包市场规模将达到 90.2 亿美元，到 2025 年将达到 97.8 亿美元，到 2033 年将达到 186.7 亿美元，预测期（2026-2033 年）的复合年增长率为 8.42%。

外包药物分析检测正在变革药物研发，并透过全面的检测方法确保药物安全。药物疗效依赖于精准的剂量控制和杂质的去除，凸显了详细分析评估的必要性。这些评估不仅优化了生产和储存流程，也有助于生物製药的特性分析，进而提升整体产品品质。对先进分析设备和专业技术人员日益增长的需求，以及许多公司内部资源的匮乏，共同推动了外包趋势的发展。此外，生物製药研发的快速发展也进一步刺激了外包检测服务的需求。最终，这种策略方法使企业能够在专注于自身核心竞争力的同时，确保其药品的完整性和安全性。

医药分析测试外包市场驱动因素

随着全球监管要求日益严格，製药公司正致力于确保药品安全性和有效性符合标准。这种严格性促使更多企业寻求专业知识以符合复杂的法规要求，从而推动了对外包分析测试服务的需求。透过利用外部服务，企业可以提高产品品质和可靠性，同时降低违规风险。这一趋势凸显了製药业向战略伙伴关係的更广泛转变，在製药业，分析测试外包对于保持竞争优势和有效满足严格的行业标准至关重要。

医药分析测试外包市场的限制因素

医药分析测试外包市场面临许多挑战，主要源自于对资料安全和保密的担忧。製药公司往往不愿将分析测试服务外包，因为共用敏感的专有资讯有潜在风险。这种担忧源于对未经授权披露和宝贵知识产权可能遭受损失的恐惧。因此，该行业已将制定强有力的网路安全措施和建立合作伙伴之间的信任作为首要任务，以缓解这些担忧。确保资料保护对于鼓励该行业对外包持更积极的态度至关重要。

医药分析测试外包市场趋势

受生物製药和生物相似药需求不断增长的推动，医药分析检测外包市场呈现显着上升趋势。随着製药公司越来越多地将生物分析检测需求外包给外包合作伙伴，它们得以获得开发复杂生物製药所需的最尖端科技和专业知识。这种策略性外包不仅提高了药物开发流程的效率，还确保了符合严格的品质和监管标准。因此，对创新疗法日益增长的需求与合约服务供应商的回应能力之间的相互作用正在重塑医药分析检测外包格局，并促进整个行业的成长与合作。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲
中东和非洲（MEA）
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争格局

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市集活动
主要企业市占率（2025 年）

主要企业简介

Eurofins Scientific SE
Laboratory Corporation of America Holdings
Charles River Laboratories International, Inc.
WuXi AppTec
SGS SA
PPD, Inc.
Intertek Group plc
Almac Group
Pace Analytical Services, LLC
Source BioScience plc
Syneos Health
BioReliance Corporation
LGC Limited
Pharmaceutical Product Development, LLC
Toxikon Corporation
Avista Pharma Solutions
Harlan Laboratories Ltd
Accutest Laboratories
Neopharm Labs Inc.

简介目录

Product Code: SQMIG35C2024

Pharmaceutical Analytical Testing Outsourcing Market size was valued at USD 9.02 Billion in 2024 and is poised to grow from USD 9.78 Billion in 2025 to USD 18.67 Billion by 2033, growing at a CAGR of 8.42% during the forecast period (2026-2033).

Pharmaceutical analytical testing outsourcing is transforming drug development and ensuring safety through comprehensive testing methodologies. The efficacy of medications is dependent on precise dosages and the absence of contaminants, highlighting the necessity for detailed analytical evaluations. These evaluations not only optimize production and storage processes but also facilitate the characterization of biologics and enhance overall product quality. The growing need for sophisticated analytical instruments and skilled professionals drives the outsourcing trend, as numerous companies lack these resources in-house. Additionally, the rapid advancement in biological development further escalates the demand for outsourced testing services. Ultimately, with this strategic approach, companies can focus on their core competencies while ensuring the integrity and safety of their pharmaceutical products.

Top-down and bottom-up approaches were used to estimate and validate the size of the Pharmaceutical Analytical Testing Outsourcing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Pharmaceutical Analytical Testing Outsourcing Market Segments Analysis

Global Pharmaceutical Analytical Testing Outsourcing Market is segmented by Services, End Use, and region. Based on Services, the market is segmented into Bioanalytical Testing (Clinical, Non-clinical), Method Development & Validation (Extractable & Leachable, Impurity Method, Technical Consulting, Others), Stability Testing (Drug Substance, Stability Indicating Method Validation, Accelerated Stability Testing, Photostability Testing, Others), Others. Based on End Use, the market is segmented into Pharmaceutical Companies, Biopharmaceutical Companies, Contract Research Organizations. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Pharmaceutical Analytical Testing Outsourcing Market

As global regulatory requirements intensify, pharmaceutical manufacturers are increasingly focused on ensuring compliance with drug safety and efficacy standards. This heightened scrutiny propels the demand for outsourced analytical testing services, as companies seek specialized expertise to navigate complex regulations. By leveraging these external services, firms can reduce the risk of non-compliance while also enhancing the quality and reliability of their products. The trend underscores a broader shift towards strategic partnerships in the pharmaceutical sector, where outsourcing analytical testing becomes essential for maintaining competitive advantage and meeting stringent industry standards effectively.

Restraints in the Pharmaceutical Analytical Testing Outsourcing Market

The pharmaceutical analytical testing outsourcing market faces significant challenges primarily due to concerns about data security and confidentiality. Companies in the pharmaceutical sector are often hesitant to outsource their analytical testing services due to the potential risks associated with sharing sensitive proprietary information. This anxiety stems from the fear of unauthorized disclosures and the potential loss of valuable intellectual property. As a result, the industry places a high priority on developing robust cybersecurity measures and fostering trust between partners to mitigate these concerns. Ensuring data protection is essential for encouraging a more open attitude towards outsourcing in this sector.

Market Trends of the Pharmaceutical Analytical Testing Outsourcing Market

The Pharmaceutical Analytical Testing Outsourcing market is experiencing a significant upward trend, primarily fueled by the escalating demand for biologic drugs and biosimilars. As pharmaceutical companies increasingly turn to outsourcing partners for their bioanalytical testing needs, they gain access to cutting-edge technologies and specialized expertise essential for developing complex biologics. This strategic outsourcing not only enhances the efficiency of drug development processes but also ensures compliance with stringent quality and regulatory standards. Consequently, the interplay between heightened demand for innovative therapeutics and the capacity of contract service providers is reshaping the landscape of pharmaceutical analytical testing outsourcing, promoting growth and collaboration across the industry.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Regulatory Landscape
PESTEL Analysis

Pharmaceutical Analytical Testing Outsourcing Market, By Services

Market Overview
Bioanalytical Testing
- Clinical
- Non-clinical
Method Development & Validation
- Extractable & Leachable
- Impurity Method
- Technical Consulting
- Others
Stability Testing
- Drug Substance
- Stability Indicating Method Validation
- Accelerated Stability Testing
- Photostability Testing
- Others
Others

Pharmaceutical Analytical Testing Outsourcing Market, By End Use

Market Overview
Pharmaceutical Companies
Biopharmaceutical Companies
Contract Research Organizations

Pharmaceutical Analytical Testing Outsourcing Market Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2025

Key Company Profiles

Eurofins Scientific SE
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Laboratory Corporation of America Holdings
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Charles River Laboratories International, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
WuXi AppTec
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SGS SA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PPD, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Intertek Group plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Almac Group
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pace Analytical Services, LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Source BioScience plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Syneos Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioReliance Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LGC Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pharmaceutical Product Development, LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Toxikon Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Avista Pharma Solutions
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Harlan Laboratories Ltd
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Accutest Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Neopharm Labs Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments